U.S. Electrical Stock News

Everus Construction Group stock closed up 3.4% today, even though the headline from this quarter is not the share price. The real story is a construction contractor reporting record numbers in revenue and earnings while the market is still pricing it below industry P/E averages. Q2 delivered roughly US$1.23b of revenue and Basic EPS of about US$1.64. Earnings over the last year have risen and profit margins have improved. The price move appears to reflect investors reacting to that earnings...

The Federal Reserve has made it clear that inflation is still the main opponent, and that interest rates could rise again if price pressures do not ease from the current 3.7% PCE level. That kind of backdrop can unsettle headline driven stocks, yet it can also highlight companies that have a record of paying reliable dividends. This article walks through 3 stocks from a High Quality Dividend Stocks screener that appear closely exposed to these cross currents. The three dividend stocks covered...

Hackett Group stock barely budged, up about 2% to close near US$11.50, even though the earnings story was all about margins rather than headline growth. The market saw another consulting quarter. The numbers showed a consulting firm pushing harder into higher value, AI enabled work with improving profitability. The real hook in this report was margin quality. Adjusted gross margin of 44.1% and adjusted EBITDA margin just over 20% framed a quarter where earnings power did more of the heavy...

Eli Lilly stock rose almost 5% today, even after a choppy week, as investors focused on one central idea. The earnings story is centered on profit power. Non GAAP earnings per share of about US$8.40 came on roughly US$23.0b in quarterly revenue and a very high gross margin near 86%. That combination is what pulled sentiment sharply higher in a single session, while the longer term chart had cooled in recent weeks. The rest of the report now matters for anyone asking whether this move has gone...

In early August 2026, IDEXX Laboratories reported past second-quarter and first-half results showing revenue of US$1,216.59 million and US$2,357.41 million respectively, with higher net income and earnings per share from continuing operations versus a year earlier. The company also slightly raised its full-year 2026 revenue, operating margin, and EPS guidance, signaling management’s confidence in ongoing growth from companion animal diagnostics and international recurring revenue...

American Well stock jumped almost 25% to US$13.02 today, a sharp move for a telehealth platform that is still reporting losses and modest revenue. The market is cheering one thing above all else. Q2 brought the closest the company has been to breakeven adjusted earnings before interest, taxes, depreciation and amortization, with an adjusted EBITDA loss of about US$1.2m on US$52m of revenue. That shift in the profit trajectory, supported by a cash pile of roughly US$196m and no debt, is what...

Par Pacific Holdings just recorded one of the punchiest profit quarters in its history, yet the stock has slumped almost 16% in a single session to about US$69. The market is reacting to concerns around a refinery cycle, while the numbers tell a different story. Q2 basic earnings per share landed at US$9.53 on revenue of US$2.97b, supported by a strong refining margin performance. For now, price action is reflecting fear. The earnings report highlights a very different kind of question: how...

In late July 2026, NeoGenomics reported second-quarter 2026 results showing sales of US$201.66 million and a return to profitability with net income of US$2.24 million, alongside higher first-half revenue and a sharply reduced year-to-date net loss. The company also raised its full-year 2026 revenue outlook to US$802 million–US$806 million and tightened its projected net loss range, which points to improving operating performance and greater confidence in its business trajectory. Next, we’ll...

PAMT just erased 18% of its market value in a day, yet the headline from this quarter is not the share price move. The key story is a fresh profit squeeze. Revenue reached US$164.7m in Q2 2026, but the company still reported a net loss of US$7.4m and basic earnings per share of a US$0.36 loss. For a stock that has looked cheap on a price to sales basis, this latest step back into deeper losses is what investors now have to process. Love PAMT's revenue scale but concerned about the fresh...

Recursion Pharmaceuticals stock closed at US$3.17, down about 4% on the day, as investors reacted quickly to another quarter of heavy spending to fuel its artificial intelligence driven drug discovery push. The headline is simple: revenue for Q2 2026 came in at US$7.67 million while the company reported a net loss of US$131.01 million, keeping the focus firmly on the cash burn story. Over a longer lens, the trailing twelve month revenue of US$54.86 million now sits against losses from...

Community Healthcare Trust stock just dropped 13.1% to US$15.39, capping a tough run over the last week and quarter, yet the core cash story looks more resilient than that move suggests. The headline from this earnings release is not earnings per share. It is the real estate investment trust engine of Funds From Operations and Adjusted Funds From Operations, with second quarter FFO of US$13.2m and AFFO of US$15.4m holding firm while the company resets its dividend policy. Is Community...

Amalgamated Financial stock barely flinched after earnings, closing up just 1% at US$50.31. The move looks modest compared with what the bank just put on the table. Q2 delivered record net income of US$34.8 million and a strong return on tangible common equity above 16%. The key question for you is whether this restrained price reaction reflects healthy skepticism or an underappreciation of how much earnings power the deposit franchise and balance sheet shift are starting to show. Is...

Freshpet just served up the kind of quarter that makes a 14.6% one day jump in the stock look less like hype and more like a gut level repricing. Heading into the release, shares had already climbed strongly in recent months. The latest print added fuel, with Q2 net sales of US$305.6m and an adjusted gross margin of 48.6% standing out in a crowded pet food aisle. The heart of this story is margin power. Adjusted EBITDA reached US$52.2m as the fresh pet food specialist showed it can turn shelf...

Elanco Animal Health stock inched up 2.4% to US$26.22 after its second quarter report, a measured move for a business that just put a far stronger profit story on the table than its trailing losses suggest. The headline is margin power. Adjusted EBITDA climbed to US$288 million and adjusted gross margin reached 58.1%, even as revenue came in at US$1.37b. Traders reacted calmly to a set of numbers that point to a company still carrying past unprofitability on its back while current quarter...

GLOBALFOUNDRIES stock came into earnings already bruised after a weak month, then dropped another 4.9% to about US$49.50 by Thursday’s close. The market leaned straight into fear even as the headline result told a more balanced story. Revenue reached US$1.786b and non International Financial Reporting Standards gross margin landed near 30%, both key markers for a contract chip manufacturer trying to prove it can turn volume into dependable profit. Today’s move looks driven more by emotion...

Digital Turbine just reminded investors that short term trading and long term narratives are not always aligned. The stock closed at US$9.51 before the results and then rose to US$13.17, a one day jump of about 38%. That kind of move usually signals a reset in expectations rather than a routine quarter. The headline this time is clear. Digital Turbine reported year on year revenue of about US$166 million and higher adjusted earnings before interest, tax, depreciation and amortization...

Vishay Precision Group entered this earnings release with a stock that had already declined over the past month, then the floor gave way. Shares closed at US$73.56 on Thursday, down about 27% in a single session, as investors reacted to a fresh quarterly loss and softening margins. The headline from the release is simple and uncomfortable. Revenue was around US$83.9m, yet Vishay Precision Group reported a net loss of about US$1.7m and lower earnings per share than in recent quarters. The gap...

The market clipped Global Ship Lease by about 2% today, yet the earnings story looks calmer than the share price suggests. Q2 revenue came in at US$198.7m with basic earnings per share of US$2.48, keeping profitability in focus for a container-ship lessor that still reports a trailing net margin of 48.7%. The bigger debate now is not whether Global Ship Lease is profitable. It is whether a stock trading on a P/E of 4.1, with a sizeable gap to a DCF-based value, is being priced on fear of...

When markets are leaning on record levels of leverage, a small shock can quickly turn into a scramble for cash, collateral and exits. That is where both risk and opportunity sit for investors watching stocks tied to prime brokerage, hedge fund financing and trading activity. This article unpacks how that leverage story touches three specific stocks, with one potentially benefiting and two that could face tougher questions. Morgan Stanley (MS) Morgan Stanley is a global financial services...

Perrigo just rose 23.1% in a single session, which indicates sentiment shifted far faster than the underlying story changed. The stock entered this report trading on a low trailing price-to-sales ratio of 0.4x, far below the broader pharmaceuticals group, and investors finally treated that discount as more than background noise. The main focus is profit tone, not revenue. After a string of heavy losses, Perrigo posted Q2 basic earnings per share of US$0.64, and net income from continuing...

Global Indemnity Group stock jumped 4.8% to US$28.52 the first trading day after earnings, which signals investors liked what they saw. The headline is simple: profitability in the core insurance engine looked solid while the expense ratio stayed heavy as the company keeps plowing money into technology and new platforms. Q2 basic earnings per share of US$0.77 and net income of US$11.1m sat on top of a quarter where the accident year combined ratio held comfortably below 100%. For an insurer...

Herc Holdings (HRI) is back in focus after reporting second quarter 2026 earnings that shifted from a net loss a year ago to a net profit, alongside higher reported sales and revenue. See our latest analysis for Herc Holdings. The strong second quarter result appears to have come alongside brisk recent trading in Herc Holdings, with a 7 day share price return of 18.05% and a 30 day share price return of 24.43%. At a latest share price of $168.83, the stock is still up 10.82% year to date and...

Sysco stock came into the print treading water after a flat month and a small decline over the past week. A 1.7% pop to US$84.21 after the earnings release signals cautious relief rather than euphoria. The market is reacting to one core message: earnings growth held up while margins stayed tight. The key headline is simple. Sysco pushed quarterly revenue to about US$22.1b and delivered adjusted earnings per share of US$1.53 with free cash flow of US$2.1b for the year. The stock’s move...

Palomar Holdings stock slipped about 1.6% today to roughly US$134, even as the company delivered another strong insurance earnings print. Adjusted net income reached US$63.8 million and adjusted earnings per share came in at US$2.36, both firmly higher than a year ago, and management lifted full year adjusted net income guidance again. So the short term price move looks muted, while the longer term story of growing premiums, a sub 80% adjusted combined ratio and high returns on equity remains...